Penumbra Pre-Tax Profit Margin 2014-2022 | PEN
Current and historical pre-tax profit margin for Penumbra (PEN) from 2014 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Penumbra pre-tax profit margin for the three months ending June 30, 2022 was .
| Penumbra Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2022-06-30 |
$0.81B |
$-0.04B |
-4.84% |
| 2022-03-31 |
$0.78B |
$-0.03B |
-3.58% |
| 2021-12-31 |
$0.75B |
$-0.01B |
-1.47% |
| 2021-09-30 |
$0.71B |
$0.03B |
4.08% |
| 2021-06-30 |
$0.67B |
$0.00B |
0.15% |
| 2021-03-31 |
$0.59B |
$-0.03B |
-4.39% |
| 2020-12-31 |
$0.56B |
$-0.04B |
-6.96% |
| 2020-09-30 |
$0.54B |
$-0.03B |
-4.83% |
| 2020-06-30 |
$0.53B |
$0.01B |
1.33% |
| 2020-03-31 |
$0.56B |
$0.04B |
6.83% |
| 2019-12-31 |
$0.55B |
$0.05B |
9.32% |
| 2019-09-30 |
$0.52B |
$0.05B |
8.80% |
| 2019-06-30 |
$0.50B |
$0.01B |
2.63% |
| 2019-03-31 |
$0.47B |
$0.01B |
1.91% |
| 2018-12-31 |
$0.45B |
$0.00B |
0.45% |
| 2018-09-30 |
$0.42B |
$-0.00B |
-0.24% |
| 2018-06-30 |
$0.39B |
$0.02B |
5.09% |
| 2018-03-31 |
$0.36B |
$0.01B |
2.47% |
| 2017-12-31 |
$0.33B |
$0.00B |
0.60% |
| 2017-09-30 |
$0.31B |
$-0.00B |
-1.29% |
| 2017-06-30 |
$0.29B |
$-0.01B |
-2.04% |
| 2017-03-31 |
$0.28B |
$-0.01B |
-1.80% |
| 2016-12-31 |
$0.26B |
$-0.00B |
-0.38% |
| 2016-09-30 |
$0.24B |
$0.00B |
1.23% |
| 2016-06-30 |
$0.23B |
$0.01B |
2.64% |
| 2016-03-31 |
$0.20B |
$0.00B |
0.98% |
| 2015-12-31 |
$0.19B |
$0.00B |
2.16% |
| 2015-06-30 |
$0.11B |
0 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$6.042B |
$0.748B |
|
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|
